| Herzuma |
Human |
trastuzumab |
trastuzumab |
EMEA/H/C/002575 |
Celltrion Healthcare Hungary Kft. |
2018/02/09
|
Authorised |
| Ozempic |
Human |
semaglutide |
semaglutide |
EMEA/H/C/004174 |
Novo Nordisk A/S |
2018/02/08
|
Authorised |
| Efavirenz/Emtricitabine/Tenofovir disoproxil Krka |
Human |
efavirenz;emtricitabine;tenofovir disoproxil |
efavirenz;emtricitabine;tenofovir disoproxil succinate |
EMEA/H/C/004274 |
KRKA, d.d., Novo mesto |
2018/02/08
|
Authorised |
| Darunavir Krka |
Human |
darunavir |
darunavir |
EMEA/H/C/004273 |
KRKA, d.d., Novo mesto |
2018/01/26
|
Authorised |
| Darunavir Krka d.d. |
Human |
darunavir |
darunavir |
EMEA/H/C/004891 |
KRKA, d.d., Novo mesto |
2018/01/18
|
Expired |
| Mvasi |
Human |
bevacizumab |
bevacizumab |
EMEA/H/C/004728 |
Amgen Technology (Ireland) UC |
2018/01/15
|
Authorised |
| Ocrevus |
Human |
ocrelizumab |
ocrelizumab |
EMEA/H/C/004043 |
Roche Registration GmbH |
2018/01/08
|
Authorised |
| Prevymis |
Human |
letermovir |
Letermovir |
EMEA/H/C/004536 |
Merck Sharp & Dohme B.V. |
2018/01/08
|
Authorised |
| Adynovi |
Human |
rurioctocog alfa pegol |
rurioctocog alfa pegol |
EMEA/H/C/004195 |
Baxalta Innovations GmbH |
2018/01/08
|
Authorised |
| Fulvestrant Mylan |
Human |
fulvestrant |
fulvestrant |
EMEA/H/C/004649 |
Mylan Pharmaceuticals Limited |
2018/01/08
|
Authorised |
| Fasenra |
Human |
benralizumab |
Benralizumab |
EMEA/H/C/004433 |
AstraZeneca AB |
2018/01/08
|
Authorised |
| Intrarosa |
Human |
prasterone |
prasterone |
EMEA/H/C/004138 |
Endoceutics S.A. |
2018/01/08
|
Authorised |
| Jorveza |
Human |
budesonide |
Budesonide |
EMEA/H/C/004655 |
Dr. Falk Pharma GmbH |
2018/01/08
|
Authorised |
| Tacforius |
Human |
tacrolimus |
tacrolimus monohydrate |
EMEA/H/C/004435 |
Teva B.V. |
2017/12/08
|
Authorised |
| Zejula |
Human |
niraparib |
niraparib (tosilate monohydrate) |
EMEA/H/C/004249 |
GlaxoSmithKline Trading Services Limited |
2017/11/16
|
Authorised |
| Ontruzant |
Human |
trastuzumab |
trastuzumab |
EMEA/H/C/004323 |
Samsung Bioepis NL B.V. |
2017/11/15
|
Authorised |
| Elebrato Ellipta |
Human |
fluticasone furoate;umeclidinium;vilanterol |
fluticasone furoate;umeclidinium bromide;vilanterol trifenatate |
EMEA/H/C/004781 |
GlaxoSmithKline Trading Services Limited |
2017/11/15
|
Authorised |
| Trelegy Ellipta |
Human |
fluticasone furoate;umeclidinium;vilanterol |
fluticasone furoate;umeclidinium bromide;vilanterol trifenatate |
EMEA/H/C/004363 |
GlaxoSmithKline Trading Services Limited |
2017/11/15
|
Authorised |
| Imatinib Teva B.V. |
Human |
imatinib |
imatinib mesilate |
EMEA/H/C/004748 |
Teva B.V. |
2017/11/15
|
Withdrawn |
| Tremfya |
Human |
guselkumab |
|
EMEA/H/C/004271 |
Janssen-Cilag International NV |
2017/11/10
|
Authorised |